Skin Cancer

The Food and Drug Administration gave the green light to a phase 1/2 trial of KSQ-001EX for patients with melanoma, head and neck squamous cell carcinoma and non-small cell lung cancer.

The FDA approved Opdivo for the treatment of patients aged 12 years and older with stage 2B or 2C melanoma that has been surgically removed

There are many immunotherapy-caused skin toxicities, though most can be easily managed.

Mohs micrographic surgery offered better survival outcomes for patients with early-stage Merkel cell carcinoma, compared with wide local excision.

"Margaritaville" singer-songwriter Jimmy Buffett died four years after receiving a diagnosis of Merkel cell carcinoma that "can be really nasty," one expert tells CURE.

‘Margaritaville’ singer-songwriter Jimmy Buffett had received a diagnosis of skin cancer followed by lymphoma four years ago, according to TMZ.

It’s been a long road since being diagnosed with melanoma in early 2020.

The Hepzato Kit is a direct-to-liver therapy for patients with uveal melanoma with hepatic metastases.

Patients with advanced Merkel cell carcinoma treated with Opdivo had improved disease-free survival rates compared with those who underwent observation.

A recent study documented the benefits of maintaining normal vitamin D levels for patients with inoperable, locally advanced or metastatic melanoma receiving anti-PD-1 immunotherapy.

A global trial recently launched that will investigate a personalized mRNA vaccine with Keytruda for patients with skin cancer.

Treatment with a CAR-M cell therapy plus Keytruda is being assessed in a phase 1 study in patients with HER2-overexpressed tumors.

The TILVANCE-301trial, expected to be completed in 2030, is the latest study of what has been described as one of the “phenomenal discoveries in melanoma.”

After two years of follow-up, patients with advanced melanoma treated with Opdivo and Opdualag continued to obtain a survival benefit compared with Opdivo alone.

Here’s an overview of the new cancer regimens that gained Food and Drug Administration (FDA) approval in the spring of this year.

From Edward James Olmos and Khloé Karsashian both discussing their cancer diagnoses to a survivor making a movie musical about her diagnosis and more, here’s what’s happening in the oncology space this week.

May is National Melanoma and Skin Cancer Awareness Month, so we took a look at some of the top stories about the disease from 2023.

The addition of a personalized cancer vaccine to Keytruda led to a 44% reduction in the risk of death or recurrence in certain patients with melanoma.

I recently experienced scanxiety after a skin check-up showed something suspicious.

I felt a kinship with the main character in the book, “A Man Called Ove,” though luckily, I had a purpose after my wife died of melanoma, and that helped to keep me going.

Two clinical trials investigating Keytruda plus Lenvima will be discontinued after the drug duo was not superior to other regimens for melanoma and colorectal cancer subsets.

From the reveal of Christine McVie’s cause of death to cancer news from Hugh Jackman and a U.S. congressman, here’s what’s happening in the oncology space this week.

From the San Diego Padres’ coach missing Opening Day for colon cancer surgery to WWE star Alexa Bliss sharing her skin cancer experience and warning people against tanning beds, here’s what’s happening in the oncology space this week.

A marathon runner who was diagnosed with metastatic melanoma learned that what she enjoyed doing before cancer could help her regain her energy and identity during and after treatment.

Patients with advanced melanoma who followed the Mediterranean diet tended to have improved responses to immunotherapy treatment, recent research showed.

When all is said and done what is important to me was that we did all we could to save her. And when that failed, we did all we could to make her passing as peaceful as possible.

This FDA approval of Zynyz was based on findings from a study which demonstrated that the therapy improves responses in patients with locally advanced Merkel cell carcinoma.

The Food and Drug Administration accepted a supplemental Biologics License Application for Opdivo to treat stage 2B or C, fully resected melanoma.

The designation is based on study findings demonstrating that the cancer vaccine-Keytruda combination reduces the risk of recurrence or death by 44% in the adjuvant setting for patients with melanoma.